Four companies on the S&P 500 shocked investors last week as their stocks soared or tumbled. Mylan was in the news and dealing with negative press following the company raising its price of EpiPens yet again angering consumers that have seen the drug’s price increase to over $600.
The four biggest movers last week were:
Mylan Inc. (MYL)
The company’s stock price has slumped over 9% in the last 5-day period. The company struggled all week to justify their drug prices. The company announced on Monday that they will release a generic version of the lifesaving EpiPen that will be priced at $300, nearly 50% less than the company’s EpiPen prices.
CF Industries Holdings (CF)
The company suffered a sporadic week in terms of stock price losing 4% last week. The stock rose 2.54% on Monday morning to the surprise of investors. The company is dealing with falling sales which slumped 13.5% in the second quarter of the year.
Net earnings fell an additional 86.7% to $47 million.
Demand is high according to the company which is a positive note, but slumping sale prices have hurt the company’s bottom line.
Regeneron Pharmaceutical (REGN)
Regeneron is down over 5% in the last 5-day period. The company’s stock is down over 1% in early morning trade on Monday. The company had an interesting week filled with positive news despite a slumping biotech sector.
The company announced a BARDA deal for MERS antibodies last week and news on Monday points to positive Phase III Praluent data.
Data showed Praluent reduced LDL-C by 50% when added to existing therapies.
Micron Technology (MU)
Micro Technology rose 6% between Wednesday and Friday last week and is up 2.24% on Monday. The company announced investor events last week, and is up 13% in the last 235 days.
Increasing chip demand puts the company on a growth path going into 2017.
HP announced last week that there was a shortage in components which Micro will use to its advantage as demand for its products remains high. The company rallied on the remark from HP.
